Evidence map›Paper›PMID 36877661›Full record

ArticleBlood advances2023

What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients.

Anna Barata, Hannah R Abrams, Christa Meyer, Lih-Wen Mau, Deborah Mattila, Linda J Burns, Christina Ullrich, Hemant Murthy, William A Wood, Effie Petersdorf and 2 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 31 citations in OpenAlex.

  1. Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Anna BarataMassachusetts General Hospital, Boston, MA.ORCID 0000-0003-0297-5920
Hannah R AbramsMassachusetts General Hospital, Boston, MA.ORCID 0000-0003-1044-7757
Christa MeyerNational Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.ORCID 0000-0003-2660-2344
Lih-Wen MauNational Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
Deborah MattilaNational Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
Linda J BurnsCenter for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
Christina UllrichHarvard Medical School, Boston, MA.
Hemant MurthyDivision of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL.
William A WoodLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Effie PetersdorfFred Hutchinson Cancer Center, Seattle, WA.
Thomas W LeBlancDuke University School of Medicine, Durham, NC.ORCID 0000-0002-0546-7895
Areej El-JawahriMassachusetts General Hospital, Boston, MA.
Harvard University · USNational Marrow Donor Program · USBoston Children's Hospital · USDuke University · USFred Hutch Cancer Center · USMayo Clinic in Florida · USMedical College of Wisconsin · USUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Palliative care (PC) benefits patients undergoing hematopoietic stem cell transplantation (HSCT), but it remains underutilized. Although transplant physicians report concerns regarding how patients perceive PC, HSCT recipients' perceptions about PC remain unaddressed. We conducted a multisite, cross-sectional survey of autologous and allogeneic HSCT recipients 3 to 12 months after transplant to assess their familiarity, knowledge, and perception of PC, as well as their unmet PC needs. We computed a composite score of patients' perceptions of PC and used a generalized linear regression model to examine factors associated with these perceptions. We enrolled 69.6% (250/359) of potential participants (median age = 58.1; 63.1% autologous HSCT). Overall, 44.3.8% (109/249) reported limited knowledge about PC and 52% (127/245) endorsed familiarity with PC. Most patients felt hopeful (54%) and reassured (50%) when they heard the term PC; 83% saw referral as a sign their doctor cared about what was happening to them. In multivariate analyses, patients who were more knowledgeable about PC were more likely to have positive perceptions of PC (B = 7.54, standard error = 1.61, P < .001). Patients' demographics, HSCT features, quality of life, and symptom burden were not significantly associated with perceptions of PC. HSCT recipients have positive perceptions of PC, though many have limited knowledge about its role. Patients who were more knowledgeable about PC were more likely to have positive perceptions of PC. These data do not support transplant physicians' negative concerns about how patients perceive PC and underscore the need to further educate patients and transplant physicians about PC.

Indexed as

Hematopoietic Stem Cell TransplantationPalliative CareCross-Sectional StudiesHumansMiddle AgedQuality of LifeTransplantation, Autologous

Identifiers

PMID36877661
PMCPMC10188629
OpenAlexW4323294373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.